CDC171: A Protein with Potential as A Drug Target Or Biomarker

Target Name: CCDC171

NCBI ID: G203238

CCDC171

CDC171: A Protein with Potential as A Drug Target Or Biomarker

CCDC171, also known as FLJ39267, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Flj1 gene family, which is known for its role in intracellular signaling.

CDC171 has been shown to play a role in a variety of physiological processes in the body, including cell signaling, neurodegeneration, and inflammation. Its expression has also been associated with a number of diseases, including neurodegenerative disorders, autoimmune diseases, and cancer.

One of the most promising aspects of CDC171 is its potential as a drug target. Researchers have identified several potential drug-like compounds that have been shown to interact with CDC171, and these compounds have been shown to have a variety of biological effects, including the inhibition of neurodegeneration and the regulation of inflammation.

In addition to its potential as a drug target, CDC171 has also been shown to be a valuable biomarker for a number of diseases. Its expression has been associated with a variety of diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The levels of CDC171 have also been used as a diagnostic marker for these diseases, with higher levels of CDC171 being associated with a more severe disease.

CDC171 is also a potential target for therapeutic intervention in a variety of other diseases, including cancer. Studies have shown that CDC171 is often overexpressed in a variety of cancer types, and that inhibition of its expression has the potential to be a therapeutic approach for cancer treatment.

Overall, CDC171 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective therapeutic approaches for the treatment of these diseases.

Protein Name: Coiled-coil Domain Containing 171

The "CCDC171 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC171 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets